Get paper from

journal cover

A specific orally active inhibitor of angiotensin-converting enzyme in man

Lancet

Apr 9, 1977

R K FergusonD N McKinstry

PMID: 66571

Get paper from

Abstract

An orally active inhibitor of the angiotensin-converting enzyme, SQ 14,225 (D-2-methyl-3-mercaptopropanoly-L-proline), was administered to fourteen normal male volunteers to evaluate its safety and efficacy in inhibiting pressor responses to exogenous angiotensin I. SQ 14,225 produced s...read more

Mentioned in this Paper

Oral Cavity
Angiotensin I
Renin-Angiotensin Pathway
Angiotensin-Converting Enzyme Inhibitors
Depressive Disorder, Treatment-Resistant
Angiotensin II Assay
Dose-Response Relationship, Drug
Angiotensin II
AGT gene
Proline
Paper Details
References
  • References4
  • Citations106
12345...

A specific orally active inhibitor of angiotensin-converting enzyme in man

Lancet

Apr 9, 1977

R K FergusonD N McKinstry

PMID: 66571

DOI:

Abstract

An orally active inhibitor of the angiotensin-converting enzyme, SQ 14,225 (D-2-methyl-3-mercaptopropanoly-L-proline), was administered to fourteen normal male volunteers to evaluate its safety and efficacy in inhibiting pressor responses to exogenous angiotensin I. SQ 14,225 produced s...read more

Mentioned in this Paper

Oral Cavity
Angiotensin I
Renin-Angiotensin Pathway
Angiotensin-Converting Enzyme Inhibitors
Depressive Disorder, Treatment-Resistant

Related Papers

Paper Details
References
  • References4
  • Citations106
12345...

Get paper from

/papers/a-specific-orally-active-inhibitor-of-angiotensin-/66571